February

February 25, 2015

Molecular therapy for Melonama: Pitx2 increases the expression of ADAR1 and inhibits melanoma progression via up regulation of its target gene, 25/February/2015, 23.16

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Molecular therapy for Melonama:  Pitx2 increases the expression of ADAR1 and inhibits melanoma progression via up regulation […]
February 25, 2015

Life-span extension therapy: Deubiquitylase HAUSP/USP7 increases the expression of Sirtuin-1 and extends life span via down regulation of its target genes, 25/February/2015, 23.10

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, L., Life-span extension therapy: Deubiquitylase HAUSP/USP7 increases the expression of Sirtuin-1 and extends life span via […]
February 25, 2015

Natural product-based therapy for Metastatic tumors: Fulvestrant, an Estrogen receptor antagonist, suppresses the expression of PD-1, a suppressor of activation of T-cells, and activates the immune system via down regulation of its target gene, 25/February/2015, 23.02

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Natural product-based therapy for Metastatic tumors: Fulvestrant, an Estrogen receptor antagonist, suppresses the expression of PD-1, a suppressor […]
February 25, 2015

MiRNA-based therapy for T2DM: MiRNA-135a-5p inhibits gluconeogenesis and hyperglycemia via up regulation of Cyclin D1, 25/February/2014, 21.22

A study from the Department of Cancer Biology, Dana-Farber Cancer Institute;  Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA; and others shows that “Cyclin D1–Cdk4 controls glucose metabolism independently of […]